Prevention of cardiovascular disease in women

被引:0
|
作者
Omer L. Shedd
Marian C. Limacher
机构
[1] University of Florida College of Medicine,Division of Cardiovascular Medicine, Department of Medicine
关键词
Bile Acid; Niacin; American Heart Association; Ezetimibe; Main Side Effect;
D O I
10.1007/s11936-003-0028-6
中图分类号
学科分类号
摘要
Appropriate screening and lifestyle modification are the foundations of effective cardiovascular disease (CVD) prevention in women. All adult women should undergo a cardiovascular risk assessment, including family history, smoking, diet, and exercise assessments, and measurement of fasting lipid profile, waist and hip dimensions, and blood pressure. Women should be advised of their 10-year estimated risk of developing a cardiovascular event using the Framingham risk calculator as recommended by the National Cholesterol Education Program. Based on the level of risk, women should receive counseling on dietary modification, physical activity, weight loss, and the need for pharmacologic intervention for blood pressure, lipid, and diabetes management. In addition, women who are overweight, have a history of gestational diabetes, or family history of diabetes should have a fasting glucose measured. Women who smoke should receive advice, encouragement, and assistance for smoking cessation. Postmenopausal hormone therapy should not be considered a treatment option for primary or secondary prevention of CVD. Women and their families should be advised of the possible signs of CVD and the need to seek immediate medical attention in the event of prolonged, new, or severe symptoms. Women with coronary artery disease especially need close attention to their risk factor levels and should receive intensive intervention to achieve optimal control.
引用
收藏
页码:287 / 298
页数:11
相关论文
共 50 条
  • [31] Updates in Cardiovascular Disease Prevention, Diagnosis, and Treatment in Women
    Jones, Sarah
    McNeil, Melissa
    Koczo, Agnes
    MEDICAL CLINICS OF NORTH AMERICA, 2023, 107 (02) : 285 - 298
  • [32] The Numbers Are In Statins for the Primary Prevention of Cardiovascular Disease in Women
    Duvernoy, Claire S.
    Blumenthal, Roger
    CIRCULATION, 2010, 121 (09) : 1063 - 1065
  • [33] Cardiovascular disease prevention in women: A rapidly evolving scenario
    Stranges, S.
    Guallar, E.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2012, 22 (12) : 1013 - 1018
  • [34] One Theoretical Framework for Cardiovascular Disease Prevention in Women
    Peterson, Jane Anthony
    JOURNAL OF CARDIOVASCULAR NURSING, 2012, 27 (04) : 295 - 302
  • [35] Cardiovascular disease prevention in women: are we up to date?
    Rapeport, Naomi
    CARDIOVASCULAR JOURNAL OF AFRICA, 2011, 22 (03)
  • [36] The Role of the Obstetrician/Gynecologist in the Prevention of Cardiovascular Disease in Women
    Ehrenthal, Deborah B.
    Nunez, Ana E.
    O'Neill, Elizabeth
    Robertson-James, Candace
    Addo, Sonya Feinberg
    Stewart, Ashley
    WOMENS HEALTH ISSUES, 2011, 21 (05) : 338 - 344
  • [37] Cardiovascular disease prevention in women: Impact of dietary interventions
    Hoekstra, Tiny
    Beulens, Joline W. J.
    van der Schouw, Yvonne T.
    MATURITAS, 2009, 63 (01) : 20 - 27
  • [38] Secondary Prevention of Cardiovascular Disease in Women: Closing the Gap
    Thakkar, Aarti
    Agarwala, Anandita
    Michos, Erin D.
    EUROPEAN CARDIOLOGY REVIEW, 2021, 16
  • [39] Cardiovascular prevention in women
    Argueso Armesto, Rosa Ma
    Diaz Diaz, Jose Luis
    GALICIA CLINICA, 2012, 73 (03): : 109 - 116
  • [40] Cardiovascular Disease Prevention in Women Reducing the Major Threat to Women's Health
    Worel, Jane Nelson
    Hayman, Laura L.
    JOURNAL OF CARDIOVASCULAR NURSING, 2015, 30 (01) : 5 - 7